SB317 makes a broad set of changes to Nevada’s industrial insurance and workers’ compensation laws. The bill revises requirements for insurers, third-party administrators, self-insured employers, and associations of self-insured employers, including where claims files may be maintained, when offices must be physically located in Nevada, and how claims may be administered. It also changes premium-calculation rules, updates audit and bonding requirements, and narrows or repeals certain provisions governing the Subsequent Injury Account for associations of self-insured employers.
The bill also makes significant procedural changes to claims handling and dispute resolution. It authorizes regulations allowing certain routine follow-up care to be delegated to physician assistants, requires adoption of the ODG drug formulary for outpatient prescription drugs, and limits reimbursement for drugs not approved under that formulary while preserving an appeal path for medically necessary exceptions. SB317 revises rules for insurer physician panels, stress-related injury claims, temporary partial disability payments, discovery in hearings, administrative fines, stays, and judicial review. It also repeals existing provisions governing certain appeals and disability-percentage determinations, replacing them with updated procedures and conforming changes throughout the industrial insurance statutes.
In practical terms, the bill updates multiple chapters of Nevada Revised Statutes governing workers’ compensation, especially chapters 616B, 616C, 616D, and 617. It affects insurers, third-party administrators, self-insured private employers, public employers, injured workers, physicians, chiropractic physicians, and mental health providers. The bill also creates new administrative obligations for the Division of Industrial Relations and the Hearings Division, including public posting of hearing calendars and maintenance of provider lists, while setting future effective dates for the formulary provisions and related transition rules.
The overall sentiment reflected in the voting history was strongly supportive and noncontroversial. SB317 passed the Senate unanimously 20-0 and the Assembly unanimously 42-0, indicating broad bipartisan agreement. No committee transcript excerpts were provided, so there is no recorded committee debate in the supplied materials to suggest organized opposition.
The main points of potential contention, based on the bill text itself, are the policy shifts that tighten or restructure claims administration and medical reimbursement. These include the new drug formulary restrictions, the elimination of the additional surety bond for third-party administrators serving associations, the sunset of certain Subsequent Injury Account claims after September 30, 2025, and the limits on discovery and stay procedures in hearings and appeals. The bill also expands some rights for injured workers, such as clearer access to provider lists and appeal rights for denied formulary exceptions, which may have helped balance concerns and contributed to the unanimous votes.
SB317 amends numerous provisions across Nevada’s industrial insurance framework, primarily in NRS chapters 616B, 616C, 616D, and 617. It changes insurer and administrator office, recordkeeping, audit, bonding, and claims-administration requirements; revises premium and assessment calculations; updates hearing and judicial-review procedures; and repeals NRS 616C.305 and 617.459. The bill also imposes a statewide outpatient drug formulary for workers’ compensation claims, modifies stress-injury and mental-health provider rules, and limits future claims against the Subsequent Injury Account for associations of self-insured employers.
The bill appears to have been broadly accepted and largely uncontroversial in the Legislature. It passed the Senate 20-0 and the Assembly 42-0, showing unanimous support in both houses. No committee transcripts were provided, so there is no additional recorded debate to indicate significant opposition or divided views.
The most notable substantive tensions in the bill are between administrative efficiency/cost control and claimant access to benefits. Provisions limiting reimbursement to drugs on the adopted formulary, restricting discovery in hearings, narrowing stay standards, and ending future claims to the Subsequent Injury Account after a cutoff date could be viewed as benefit-limiting or insurer-friendly. At the same time, the bill strengthens some worker-facing protections, such as preserving appeals for denied medically necessary drugs, requiring more robust physician and mental-health provider lists, and clarifying that physicians generally cannot be removed from insurer lists except as expressly allowed. No specific stakeholder objections were provided in the record.